DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for diphenhydramine hydrochloride; ibuprofen and what is the scope of patent protection?
Diphenhydramine hydrochloride; ibuprofen
is the generic ingredient in two branded drugs marketed by Haleon Us Holdings, Aurobindo Pharma Ltd, Bionpharma, and Strides Pharma, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.Seventeen suppliers are listed for this compound.
Summary for DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 17 |
Clinical Trials: | 12 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN |
DailyMed Link: | DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN at DailyMed |
Recent Clinical Trials for DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Guangzhou Kangqi Medical Technology Co., LTD | Phase 1 |
Overseas Pharmaceuticals, Ltd. | Phase 1 |
HALEON | Phase 1 |
See all DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN clinical trials
Pharmacology for DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Drug Class | Histamine-1 Receptor Antagonist Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors Histamine H1 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Paragraph IV (Patent) Challenges for DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ADVIL PM | Capsules | diphenhydramine hydrochloride; ibuprofen | 200 mg/25 mg | 021393 | 2016-02-16 |
US Patents and Regulatory Information for DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haleon Us Holdings | ADVIL PM | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 021393-001 | Dec 21, 2005 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Strides Pharma | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 200888-001 | Mar 5, 2012 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bionpharma | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 090397-001 | Nov 22, 2010 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Ltd | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 210676-001 | Feb 14, 2019 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | ADVIL PM | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 021393-001 | Dec 21, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Haleon Us Holdings | ADVIL PM | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 021393-001 | Dec 21, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.